DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 17 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 468,620 | $1,336,000 | 1.68% |
| Anson Funds Management LP | 654,762 | $1,866,000 | 0.47% |
| Swift Run Capital | 14,545 | $41,000 | 0.04% |
| Virtu Financial LLC | 11,864 | $34,000 | 0.00% |
| Advisor Group, Inc. | 940 | $3,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 667 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 149,875 | $427,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,060 | $28,000 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $0 | 0.00% |